1428929-06-9Relevant articles and documents
Discovery and evaluation of novel FAAH inhibitors in neuropathic pain model
Bhuniya, Debnath,Kharul, Rajendra K.,Hajare, Atul,Shaikh, Nadim,Bhosale, Sandeep,Balwe, Sandip,Begum, Fouzia,De, Siddhartha,Athavankar, Sonalee,Joshi, Dhananjay,Madgula, Vamsi,Joshi, Kaushal,Raje, Amol A.,Meru, Ashwinkumar V.,Magdum, Amol,Mookhtiar, Kasim A.,Barbhaiya, Rashmi
supporting information, p. 238 - 243 (2018/12/05)
Conceptual design and modification of urea moiety in chemotype PF-3845/04457845, the bench marking irreversible inhibitor of fatty acid amide hydrolase (FAAH), led to discovery of a novel nicotinamide-based lead 12a having reversible mechanism of action.
AMIDE COMPOUNDS, COMPOSITIONS AND APPLICATIONS THEREOF
-
Page/Page column 49-50, (2013/04/10)
The present disclosure relates to substituted amide compounds that are inhibitors of Fatty Acid Amide Hydrolase (FAAH), their stereoisomers, tautomers, prodrugs, polymorphs, solvates, pharmaceutically acceptable salts, and pharmaceutical compositions cont
